From the October Shareholder Update: "We have b
Post# of 22454
"We have been successful in continuing to raise funds to meet the company’s immediate needs and to sustain the continued progress in our labs. We have not yet been able to secure the funds necessary to return the company to a point of long term equilibrium. We are currently negotiating with a high profile technology investment group for a potential equity investment and we have signed an LOI with another strategic funding group."